CN110839884A - Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof - Google Patents
Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof Download PDFInfo
- Publication number
- CN110839884A CN110839884A CN201911227592.XA CN201911227592A CN110839884A CN 110839884 A CN110839884 A CN 110839884A CN 201911227592 A CN201911227592 A CN 201911227592A CN 110839884 A CN110839884 A CN 110839884A
- Authority
- CN
- China
- Prior art keywords
- powder
- vitamin
- oil
- fat
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 44
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 36
- 230000002757 inflammatory effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 100
- 235000019197 fats Nutrition 0.000 claims abstract description 78
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 72
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 72
- 235000021119 whey protein Nutrition 0.000 claims abstract description 72
- 235000021323 fish oil Nutrition 0.000 claims abstract description 52
- 235000018102 proteins Nutrition 0.000 claims abstract description 37
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 37
- 239000004006 olive oil Substances 0.000 claims abstract description 35
- 235000008390 olive oil Nutrition 0.000 claims abstract description 35
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 31
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 31
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 25
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 25
- 238000002156 mixing Methods 0.000 claims abstract description 25
- 239000003921 oil Substances 0.000 claims abstract description 25
- 235000019198 oils Nutrition 0.000 claims abstract description 25
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 25
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 23
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 15
- 235000019482 Palm oil Nutrition 0.000 claims abstract description 14
- 244000272459 Silybum marianum Species 0.000 claims abstract description 14
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 14
- 239000010495 camellia oil Substances 0.000 claims abstract description 14
- 239000002540 palm oil Substances 0.000 claims abstract description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 14
- 239000003240 coconut oil Substances 0.000 claims abstract description 11
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 11
- 206010061218 Inflammation Diseases 0.000 claims abstract description 8
- 230000004054 inflammatory process Effects 0.000 claims abstract description 8
- 102000015636 Oligopeptides Human genes 0.000 claims description 60
- 108010038807 Oligopeptides Proteins 0.000 claims description 60
- 239000000835 fiber Substances 0.000 claims description 42
- 241000209140 Triticum Species 0.000 claims description 33
- 235000021307 Triticum Nutrition 0.000 claims description 33
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 32
- 235000006708 antioxidants Nutrition 0.000 claims description 28
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 26
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 26
- 239000011707 mineral Substances 0.000 claims description 26
- 229940088594 vitamin Drugs 0.000 claims description 26
- 229930003231 vitamin Natural products 0.000 claims description 26
- 235000013343 vitamin Nutrition 0.000 claims description 26
- 239000011782 vitamin Substances 0.000 claims description 26
- 241000251511 Holothuroidea Species 0.000 claims description 25
- 239000005913 Maltodextrin Substances 0.000 claims description 19
- 229920002774 Maltodextrin Polymers 0.000 claims description 19
- 229940035034 maltodextrin Drugs 0.000 claims description 19
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 18
- 241000251468 Actinopterygii Species 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 102000008186 Collagen Human genes 0.000 claims description 18
- 108010035532 Collagen Proteins 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 229920001436 collagen Polymers 0.000 claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 17
- 229930003427 Vitamin E Natural products 0.000 claims description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 16
- 235000019165 vitamin E Nutrition 0.000 claims description 16
- 239000011709 vitamin E Substances 0.000 claims description 16
- 229940046009 vitamin E Drugs 0.000 claims description 16
- 210000000988 bone and bone Anatomy 0.000 claims description 15
- 235000013325 dietary fiber Nutrition 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 241001506047 Tremella Species 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 13
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- 229940026510 theanine Drugs 0.000 claims description 13
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 12
- 229920002498 Beta-glucan Polymers 0.000 claims description 12
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 12
- 229910052725 zinc Inorganic materials 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 235000012661 lycopene Nutrition 0.000 claims description 11
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 11
- 239000001751 lycopene Substances 0.000 claims description 11
- 229960004999 lycopene Drugs 0.000 claims description 11
- 239000011669 selenium Substances 0.000 claims description 11
- 229910052711 selenium Inorganic materials 0.000 claims description 11
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 10
- 240000002624 Mespilus germanica Species 0.000 claims description 10
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 10
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 235000008599 Poria cocos Nutrition 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 10
- 229910052698 phosphorus Inorganic materials 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 9
- 229930003451 Vitamin B1 Natural products 0.000 claims description 9
- 229930003779 Vitamin B12 Natural products 0.000 claims description 9
- 229930003471 Vitamin B2 Natural products 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 229930003316 Vitamin D Natural products 0.000 claims description 9
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 9
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 235000013734 beta-carotene Nutrition 0.000 claims description 9
- 239000011648 beta-carotene Substances 0.000 claims description 9
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 9
- 229960002747 betacarotene Drugs 0.000 claims description 9
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 9
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 9
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- 229940055726 pantothenic acid Drugs 0.000 claims description 9
- 235000019161 pantothenic acid Nutrition 0.000 claims description 9
- 239000011713 pantothenic acid Substances 0.000 claims description 9
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- 235000019155 vitamin A Nutrition 0.000 claims description 9
- 239000011719 vitamin A Substances 0.000 claims description 9
- 235000010374 vitamin B1 Nutrition 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- 235000019163 vitamin B12 Nutrition 0.000 claims description 9
- 239000011715 vitamin B12 Substances 0.000 claims description 9
- 235000019164 vitamin B2 Nutrition 0.000 claims description 9
- 239000011716 vitamin B2 Substances 0.000 claims description 9
- 235000019158 vitamin B6 Nutrition 0.000 claims description 9
- 239000011726 vitamin B6 Substances 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 235000019166 vitamin D Nutrition 0.000 claims description 9
- 239000011710 vitamin D Substances 0.000 claims description 9
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- 229940011671 vitamin b6 Drugs 0.000 claims description 9
- 229940046008 vitamin d Drugs 0.000 claims description 9
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 9
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 240000006162 Chenopodium quinoa Species 0.000 claims description 7
- 241000207199 Citrus Species 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 7
- 235000020971 citrus fruits Nutrition 0.000 claims description 7
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 7
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 7
- 229940038580 oat bran Drugs 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 235000015099 wheat brans Nutrition 0.000 claims description 7
- 241000222336 Ganoderma Species 0.000 claims description 6
- 240000001080 Grifola frondosa Species 0.000 claims description 6
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 241000675108 Citrus tangerina Species 0.000 claims description 4
- 208000035269 cancer or benign tumor Diseases 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 102000004407 Lactalbumin Human genes 0.000 claims description 3
- 108090000942 Lactalbumin Proteins 0.000 claims description 3
- 244000082204 Phyllostachys viridis Species 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- 229940092258 rosemary extract Drugs 0.000 claims description 3
- 235000020748 rosemary extract Nutrition 0.000 claims description 3
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 3
- 244000077995 Coix lacryma jobi Species 0.000 claims description 2
- 241001523681 Dendrobium Species 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 240000005373 Panax quinquefolius Species 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 3
- -1 mannose oligosaccharide Chemical class 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000000750 progressive effect Effects 0.000 abstract description 3
- 235000003715 nutritional status Nutrition 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 description 21
- 241001122767 Theaceae Species 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 229920002307 Dextran Polymers 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940057917 medium chain triglycerides Drugs 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 208000002720 Malnutrition Diseases 0.000 description 5
- 235000019486 Sunflower oil Nutrition 0.000 description 5
- 235000000824 malnutrition Nutrition 0.000 description 5
- 230000001071 malnutrition Effects 0.000 description 5
- 208000015380 nutritional deficiency disease Diseases 0.000 description 5
- 239000002600 sunflower oil Substances 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000965254 Apostichopus japonicus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a nutritional composition for improving body inflammatory signs of tumor patients and a preparation method thereof, wherein the nutritional composition comprises the following components in parts by weight: 20-50 parts of protein, 10-30 parts of fat and 20-60 parts of carbohydrate; the preparation method comprises the following steps: uniformly mixing one or more of olive oil, sunflower seed oil, coconut oil, silybum marianum seed oil, tea seed oil, palm oil and medium-chain triglyceride, and sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder to prepare compound vegetable fat powder; mixing fish oil, phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder to obtain fish oil fat powder; and uniformly mixing the compound vegetable fat powder and the fish oil fat powder, and adding concentrated whey protein and the like to prepare the nutritional composition. The invention can improve the nutritional status, the inflammation level and the immunity level of a tumor patient in the progressive stage, improve the treatment tolerance and prolong the life cycle of the patient.
Description
Technical Field
The invention belongs to the technical field of body metabolism improving products, and particularly relates to a nutritional composition for improving body inflammatory signs of tumor patients and a preparation method thereof.
Background
The treatment of malignant tumors has advanced greatly in the past 20 years, but the morbidity and mortality of malignant tumors are still high, and the malignant tumors are one of the important reasons threatening the health of human beings. Worldwide, patients who die from malignancies account for approximately 13% of total deaths, and about 1/5 of them die from cancer-related malnutrition and its complications, not from cancer itself. Research shows that the incidence rate of malnutrition of malignant tumor patients is higher and can reach 40-80%, and the difference of the incidence rate is derived from different individual differences, different tumor types, different stages and the like.
The treatment of malignant tumor can be directly influenced by the poor nutritional state, the malignant tumor patients with nutritional risk or malnutrition not only have poorer quality of life, prolonged hospitalization time and increased incidence of infection and fatality rate, but also delay the operation time and influence the postoperative recovery due to malnutrition, and simultaneously, the tolerance and sensitivity of the patients to radiotherapy and chemotherapy are also poorer. Therefore, for malignant tumor patients with malnutrition, reasonable and effective nutrition has important significance for improving the nutrition condition of the patients and further treating and recovering the tumor patients.
Disclosure of Invention
In order to solve the above problems in the prior art, the present invention aims to provide a nutritional composition for improving body inflammatory signs of tumor patients and a preparation method thereof.
The technical scheme adopted by the invention is as follows:
a nutritional composition for improving body inflammatory signs of a patient with a tumor comprises the following components in parts by weight: 20-50 parts of protein, 10-30 parts of fat and 20-60 parts of carbohydrate.
Further, the protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide; the weight percentage of the whey protein in the protein is more than 50%.
Among them, whey protein is a high-quality protein, which is often used as a high-quality protein supplement for human body, and is called "protein king", which is not only easily digested and absorbed, but also contains various active ingredients. The whey protein hydrolysate is obtained by hydrolyzing whey protein, and most of the components are small peptides and amino acids, so that the sensitivity of the whey protein to hot acid is improved. Most researchers have shown that whey protein after hydrolysis also releases some amino acid sequences with specific activity, i.e. active peptides, which have specific physiological functions. The short peptide generated by hydrolyzing the whey protein has the characteristics of low osmotic pressure, low antigenicity and good intestinal tolerance, can be directly and uniformly absorbed, simultaneously promotes the utilization of nutrient substances by intestinal microorganisms, promotes the absorption of amino acids and trace elements, integrally improves the digestion utilization rate of a patient organism, can correct negative nitrogen balance, and is not easy to cause gastrointestinal adverse reactions such as allergy, diarrhea and the like of the patient.
The wheat oligopeptide is a small molecular polypeptide mixture obtained by taking wheat gluten as a raw material through directional enzyme digestion and a specific small peptide separation technology, the main component of the wheat oligopeptide is a small peptide consisting of 2-6 amino acid molecules, and the wheat oligopeptide has the characteristics of bitter taste, good water solubility, stable dispersion, easy absorption, strong biological activity and the like. The wheat oligopeptide has balanced amino acid content, is almost the same as wheat protein, has the highest glutamic acid content, and exists mostly in the form of glutamine. The wheat oligopeptide can enhance the activity of antioxidant enzyme, inhibit lipid peroxidation and accelerate the removal of free radicals in vivo. Meanwhile, the in vitro antioxidant experiment shows that the wheat oligopeptide has in vitro reducing capacity, contains rich glutamine, can stimulate the proliferation of lymphocytes of the organism, enhances the phagocytic function of macrophages, and improves the anti-infection capacity and immunity of the organism.
The dried organic components of the sea cucumber body wall comprise 90 percent of protein (polypeptide), 6 percent of poly (oligo) sugar and 4 percent of lipid, and contain calcium, magnesium salt, a plurality of trace elements and a small amount of nucleic acid, and the sea cucumber body wall is a high-quality food with high protein, low fat, low cholesterol, high vitamins and minerals, thereby determining that the sea cucumber body wall has the effects of resisting angiogenesis, tumors, coagulation, blood pressure, inflammation, bacteria, oxidation, thrombosis, cancer and the like. The sea cucumber peptide is a protein hydrolysate which is prepared by taking fresh and alive sea cucumbers as raw materials, hydrolyzing by protease, separating and purifying, mainly comprises small molecular peptides and coexists with various functional components. Generally consists of 3-10 amino acids, and the components with the molecular mass of less than 2000 u account for more than 90%. The body wall of Stichopus japonicus contains multiple active polypeptides, wherein pentapeptide (relative molecular mass is 568.1) separated from epithelial tissue and composed of amino acids such as leucine, proline, serine, arginine, etc. has antitumor and antiinflammatory activity. The sea cucumber peptide can be obtained by enzymolysis of sea cucumber protein, has good solubility, stability and low viscosity, and has great application potential.
Preferably, the mass ratio of the concentrated whey protein in the protein is more than 50%, and the mass ratio of the hydrolyzed whey protein in the protein is more than 20%, so that the protein absorption and utilization rate is high.
Further, the fat contains fish oil, olive oil, medium chain triglycerides, DHA and EPA; the fish oil accounts for 8-20% of the fat, the olive oil accounts for 20-40% of the fat, the medium chain triglyceride accounts for 20-40% of the fat, and the DHA and the EPA account for 1-6% of the fat.
The main component of olive oil is oleic acid, which belongs to omega-9 MUFA and contains high contents of α -tocopherol, squalene, phytosterol, triterpenes and phenolic compounds, and high content of α -tocopherol can reduce oxidative damage and has antioxidant and anti-inflammatory effects.
The content of unsaturated fatty acid in the sunflower seed oil is up to more than 90%, and the human body digestibility of the sunflower seed oil is up to more than 96%; the sunflower seed oil is rich in vitamin E, carotene, magnesium, phosphorus, sodium, calcium, iron, potassium, zinc and other nutrient substances, and is called healthy edible oil.
Wherein, the medium chain triglyceride is metabolized without the help of carnitine, and is fast in digestion and absorption, thus being very suitable for patients with liver, gallbladder and intestine diseases, renal disease patients with renal insufficiency, postoperative patients with physical weakness, infants and other people. MCT has low metabolic yield and high metabolic speed and cannot be converted into fat in vivo.
Further, the carbohydrate is mainly composed of maltodextrin.
The composition further comprises dietary fiber, wherein the dietary fiber is one or more of mannose oligomer, oat β -glucan, yeast β -glucan, galactooligosaccharide, xylooligosaccharide, fructooligosaccharide, isomaltooligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
Furthermore, the composition also comprises medicinal and edible raw materials; the medicinal and edible raw materials are one or more of medlar, rhizoma polygonati, dried orange peel, poria cocos, grifola frondosa, coix seeds, Chinese yam, lotus seeds, dendrobium, lucid ganoderma and American ginseng; also comprises theanine, tremella polysaccharide and phospholipid; the composition further comprises an antioxidant; the antioxidant is one or more of lycopene, tea polyphenol, vitamin E, rosemary extract and bamboo leaf antioxidant.
The composition further comprises vitamins and minerals, wherein the minerals are one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamins are one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
Further, the composition comprises, by weight, 20-30 parts of concentrated whey protein, 5-10 parts of hydrolyzed whey protein, 0.6 part of mannose oligomer, 0.6 part of tremella polysaccharide, 0.2 part of wheat oligopeptide, 0.2 part of marine fish collagen oligopeptide, 0.004 part of sea cucumber oligopeptide powder, 0.004 part-0.2 part of tea theanine, 0.2 part of oat β -glucan, 0.112 part of medlar powder, 0.088 part of tuckahoe powder, 0.088 part of sealwort powder, 0.06 part of dried orange peel powder, 0.3 part of vitamin, 1.7 parts of mineral source, 25-50 parts of compound vegetable fat powder, 2-10 parts of fish oil fat powder, 0.0008 part of lycopene, 0.5-1.5 part of edible essence and 20-35 parts of maltodextrin;
the compound vegetable fat powder is prepared by uniformly mixing one or more of olive oil, sunflower seed oil, coconut oil, silybum marianum seed oil, tea seed oil, palm oil and medium-chain triglyceride, and sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder; the fish oil fat powder is prepared by mixing fish oil, phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder;
the mineral source is one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamin is one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
A method of preparing a nutritional composition for ameliorating the signs of body inflammation in a patient with a neoplasm, comprising the steps of:
mixing one or more of oleum Olivarum, oleum Helianthi, oleum Cocois, Silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride, sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and lactalbumin, stirring and mixing; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; carrying out spray drying on the transparent emulsion to obtain compound vegetable fat powder;
stirring and uniformly mixing fish oil, phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; spray drying the transparent emulsion to obtain fish oil fat powder;
uniformly mixing the compound plant fat powder and the fish oil fat powder, sequentially adding concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide, sea cucumber oligopeptide powder, oligomannose, tremella polysaccharide, oat β -glucan, tea theanine, medlar powder, rhizoma polygonati powder, tuckahoe powder, tangerine peel powder, vitamins, a mineral source, maltodextrin, lycopene and edible essence, and uniformly mixing to obtain the nutritional composition.
The invention has the beneficial effects that: the nutritional composition for improving body inflammatory signs of tumor patients and the composition prepared by the preparation method are composed of protein, fat, carbohydrate, dietary fiber, vitamins, minerals and other nutritional ingredients; the total energy of each 100g of the composition is 430-500kcal, and the composition can provide higher energy, higher quality fat, high quality protein, control carbohydrate supply, add functional nutrient raw materials, natural antioxidant, vitamin and mineral substances from the nutritional requirement of a progressive tumor patient, improve the nutritional status, the inflammation level and the immunity level of the progressive tumor patient, improve the treatment tolerance and prolong the life cycle of the patient.
Detailed Description
The present invention is further illustrated below with reference to specific examples.
Example 1
A nutritional composition for improving body inflammatory signs of a patient with a tumor comprises the following components in parts by weight: 25 parts of protein, 15 parts of fat and 60 parts of carbohydrate.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The carbohydrate is mainly maltodextrin.
The fat contains fish oil, olive oil, medium chain triglyceride, DHA and EPA; the fish oil accounts for 15% of the fat, the olive oil accounts for 20% of the fat, the medium chain triglyceride accounts for 20% of the fat, and the DHA and the EPA account for 1% of the fat.
Example 2
A nutritional composition for improving body inflammatory signs of a patient with a tumor comprises the following components in parts by weight: 40 parts of protein, 30 parts of fat and 30 parts of carbohydrate. The mass ratio of concentrated whey protein in the protein is 50%, and the mass ratio of hydrolyzed whey protein in the protein is 20%. The carbohydrate is mainly maltodextrin.
The fat contains fish oil, olive oil, medium chain triglyceride, DHA and EPA; the weight percentage of the fish oil in the fat is 20%, the weight percentage of the olive oil in the fat is 30%, the weight percentage of the medium chain triglyceride in the fat is 25%, the weight percentage of the sunflower seed oil in the fat is 25%, and the weight percentage of DHA and EPA in the fat is 5%.
Example 3
A nutritional composition for improving body inflammatory signs of a patient with a tumor comprises the following components in parts by weight: 40 parts of protein, 20 parts of fat and 40 parts of carbohydrate; the carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide; the fat contains fish oil, olive oil, medium chain triglyceride, sunflower seed oil, DHA and EPA; the fish oil accounts for 20% of the fat, the olive oil accounts for 30% of the fat, the medium chain triglyceride accounts for 25% of the fat, the sunflower seed oil accounts for 25% of the fat, and the DHA and the EPA account for 3% of the fat.
Example 4
A nutritional composition for improving body inflammatory signs of a patient with a tumor comprises the following components in parts by weight: 50 parts of protein, 15 parts of fat and 35 parts of carbohydrate.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide. The carbohydrate is maltodextrin.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fat comprises olive oil, sunflower oil, medium chain triglycerides and fish oil; the fish oil accounts for 15% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:1: 1.
Example 5
A nutritional composition for improving body inflammatory signs of tumor patients comprises the following components in parts by weight: 35 parts of protein, 22 parts of fat, 35 parts of carbohydrate and dietary fiber. The carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fat comprises olive oil, sunflower oil, medium chain triglycerides and fish oil; the fish oil accounts for 10% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:1: 1.
The dietary fiber is one or more of oligomannose, oat β -dextran, yeast β -dextran, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
Example 6
A nutritional composition for improving body inflammatory signs of tumor patients comprises the following components in parts by weight: 38 parts of protein, 18 parts of fat, 32 parts of carbohydrate, dietary fiber and medicinal and edible raw materials. The carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fat comprises olive oil, sunflower oil, medium chain triglycerides and fish oil; the fish oil accounts for 12% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:1: 1.
The dietary fiber is one or more of oligomannose, oat β -dextran, yeast β -dextran, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
The medicinal and edible raw materials are one or more of fructus Lycii, rhizoma Polygonati, pericarpium Citri Tangerinae, Poria, Maitake Mushroom, Coicis semen, rhizoma Dioscoreae, semen Nelumbinis, herba Dendrobii, Ganoderma and radix Panacis Quinquefolii.
Example 7
A nutritional composition for improving body inflammatory signs of tumor patients comprises the following components in parts by weight: 20 parts of protein, 28 parts of fat, 43 parts of carbohydrate, dietary fiber, medicinal and edible raw materials, theanine, tremella polysaccharide and phospholipid. The carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fat comprises olive oil, sunflower oil, medium chain triglycerides and fish oil; the fish oil accounts for 10% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:1: 1.
The dietary fiber is one or more of oligomannose, oat β -dextran, yeast β -dextran, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
The medicinal and edible raw materials are one or more of fructus Lycii, rhizoma Polygonati, pericarpium Citri Tangerinae, Poria, Maitake Mushroom, Coicis semen, rhizoma Dioscoreae, semen Nelumbinis, herba Dendrobii, Ganoderma and radix Panacis Quinquefolii.
The composition also comprises vitamins and minerals, wherein the minerals are one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamins are one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
Example 8
A nutritional composition for improving body inflammatory signs of tumor patients comprises the following components in parts by weight: 22 parts of protein, 14 parts of fat, 60 parts of carbohydrate, dietary fiber, medicinal and edible raw materials, tea theanine, zinc, selenium, tremella polysaccharide, phospholipid and an antioxidant. The carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fat comprises olive oil, sunflower oil, medium chain triglycerides and fish oil; the fish oil accounts for 14% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:1: 1.
The dietary fiber is one or more of oligomannose, oat β -dextran, yeast β -dextran, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
The medicinal and edible raw materials are one or more of fructus Lycii, rhizoma Polygonati, pericarpium Citri Tangerinae, Poria, Maitake Mushroom, Coicis semen, rhizoma Dioscoreae, semen Nelumbinis, herba Dendrobii, Ganoderma and radix Panacis Quinquefolii; the antioxidant is one or more of lycopene, tea polyphenols, vitamin E, herba Rosmarini officinalis extract and folium Bambusae antioxidant.
The composition also comprises vitamins and minerals, wherein the minerals are one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamins are one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
Example 9
A nutritional composition for improving body inflammatory signs of tumor patients comprises the following components in parts by weight: 40 parts of protein, 10 parts of fat, 20 parts of carbohydrate, dietary fiber, medicinal and edible raw materials, theanine, zinc, selenium, tremella polysaccharide, phospholipid, antioxidant, vitamin and mineral substances. The carbohydrate is maltodextrin.
The protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide.
The fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride; the fish oil accounts for 14% of the fat by mass, and the weight ratio of the olive oil, the sunflower seed oil and the medium chain triglyceride is 1:0.9: 0.9.
The dietary fiber is one or more of oligomannose, oat β -dextran, yeast β -dextran, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran powder fiber, quinoa fiber, wheat fiber and wheat bran powder fiber.
The medicinal and edible raw materials are one or more of fructus Lycii, rhizoma Polygonati, pericarpium Citri Tangerinae, Poria, Maitake Mushroom, Coicis semen, rhizoma Dioscoreae, semen Nelumbinis, herba Dendrobii, Ganoderma and radix Panacis Quinquefolii; the antioxidant is one or more of lycopene, tea polyphenols, vitamin E, herba Rosmarini officinalis extract and folium Bambusae antioxidant.
The composition also comprises vitamins and minerals, wherein the minerals are one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamins are one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
Example 10
A nutritional composition for improving body inflammatory signs of tumor patients comprises, by weight, 30 parts of concentrated whey protein, 10 parts of hydrolyzed whey protein powder, 0.6 part of oligomannose, 0.6 part of tremella polysaccharide, 0.2 part of wheat oligopeptide, 0.2 part of marine fish collagen oligopeptide, 0.004 part of sea cucumber oligopeptide powder, 0.004 part of tea theanine, 0.2 part of oat β -glucan, 0.112 part of medlar powder, 0.088 part of tuckahoe powder, 0.088 part of sealwort powder, 0.06 part of dried orange peel powder, 0.3 part of vitamin, 1.7 parts of mineral source, 25 parts of compound vegetable fat powder, 3 parts of fish oil fat powder, 0.0008 part of lycopene, 0.5 part of edible essence and the balance of maltodextrin;
the compound vegetable fat powder is prepared by uniformly mixing one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium-chain triglyceride, and sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder;
the mineral source is one or more of ferrum, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamin is one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
A method of preparing a nutritional composition for ameliorating the signs of body inflammation in a patient with a neoplasm, comprising the steps of:
mixing one or more of oleum Olivarum, oleum Helianthi, oleum Cocois, fish oil, Silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride, sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and lactalbumin, stirring and mixing; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; carrying out spray drying on the transparent emulsion to obtain compound vegetable fat powder;
adding concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide, sea cucumber oligopeptide powder, oligomannose, tremella polysaccharide, oat β -glucan, tea theanine, medlar powder, rhizoma polygonati powder, tuckahoe powder, tangerine peel powder, vitamins, mineral sources and maltodextrin in sequence into the compound vegetable fat powder, and uniformly mixing to obtain the nutritional composition.
Example 11
A nutritional composition for improving body inflammatory signs of tumor patients comprises, by weight, 21 parts of concentrated whey protein, 7 parts of hydrolyzed whey protein powder, 0.6 part of oligomannose, 0.6 part of tremella polysaccharide, 0.2 part of wheat oligopeptide, 0.2 part of marine fish collagen oligopeptide, 0.004 part of sea cucumber oligopeptide powder, 0.004 part of tea theanine, 0.2 part of oat β -glucan, 0.112 part of medlar powder, 0.088 part of tuckahoe powder, 0.088 part of sealwort powder, 0.06 part of dried orange peel powder, 0.3 part of vitamin, 1.7 parts of mineral source, 36 parts of compound vegetable fat powder, 6 parts of fish oil fat powder, 0.0008 part of lycopene, 1.08 part of edible essence and the balance of maltodextrin;
the compound vegetable fat powder comprises the following components in parts by weight: 18 parts of olive oil, 16 parts of sunflower seed oil, 15.999 parts of medium-chain triglyceride, 23.96 parts of isomaltooligosaccharide, 25 parts of whey protein powder, 1 part of phospholipid, 0.04 part of tea polyphenol and 0.001 part of vitamin E.
The fish oil fat powder comprises the following components in parts by weight: 40 parts of fish oil, 25 parts of isomaltooligosaccharide, 35 parts of whey protein powder, 1 part of phospholipid, 0.035 part of vitamin E, 0.015 part of tea polyphenol, 0.01 part of rosemary extract and 0.18 part of bamboo leaf antioxidant.
The mineral source is one or more of ferrum, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamin is one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
A method of preparing a nutritional composition for ameliorating the signs of body inflammation in a patient with a neoplasm, comprising the steps of:
uniformly mixing olive oil, sunflower seed oil and medium-chain triglyceride, sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder, and uniformly stirring; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; carrying out spray drying on the transparent emulsion to obtain compound vegetable fat powder;
stirring and uniformly mixing fish oil, antioxidant, phospholipid, isomaltooligosaccharide and whey protein powder; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; spray drying the transparent emulsion to obtain fish oil fat powder;
uniformly mixing the compound plant fat powder and the fish oil fat powder, sequentially adding concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide, sea cucumber oligopeptide powder, oligomannose, tremella polysaccharide, oat β -glucan, tea theanine, medlar powder, rhizoma polygonati powder, tuckahoe powder, tangerine peel powder, vitamins, mineral sources, maltodextrin, lycopene and edible essence, and uniformly mixing to obtain the nutritional composition.
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (10)
1. A nutritional composition for ameliorating the signs of physical inflammation in a patient with a neoplasm, said nutritional composition comprising: comprises the following components in parts by weight: 20-50 parts of protein, 10-30 parts of fat and 20-60 parts of carbohydrate.
2. Nutritional composition for improving body inflammatory signs in oncology patients according to claim 1, characterized in that: the protein is one or more of whey protein, concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide and sea cucumber oligopeptide; the weight percentage of the whey protein in the protein is more than 50%.
3. Nutritional composition for improving body inflammatory signs in oncology patients according to claim 1, characterized in that: the fat is one or more of olive oil, sunflower seed oil, coconut oil, fish oil, silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride.
4. Nutritional composition for improving body inflammatory signs in oncology patients according to claim 1, characterized in that: the fat contains fish oil, olive oil, medium chain triglyceride, DHA and EPA; the fish oil accounts for 8-20% of the fat, the olive oil accounts for 20-40% of the fat, the medium chain triglyceride accounts for 20-40% of the fat, and the DHA and the EPA account for 1-6% of the fat.
5. Nutritional composition for improving body inflammatory signs in oncology patients according to claim 1, characterized in that: the carbohydrate consists essentially of maltodextrin.
6. The nutritional composition for ameliorating inflammatory signs in a body of a subject having a tumor according to claim 1, further comprising dietary fiber, wherein the dietary fiber is one or more of mannose oligosaccharide, oat β -glucan, yeast β -glucan, galacto-oligosaccharide, xylo-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, arabinose, resistant dextrin, citrus fiber, apple fiber, oat bran fiber, quinoa fiber, wheat fiber, and wheat bran fiber.
7. Nutritional composition for improving body inflammatory signs in oncology patients according to claim 1, characterized in that: also comprises medicinal and edible raw materials; the medicinal and edible raw materials are one or more of medlar, rhizoma polygonati, dried orange peel, poria cocos, grifola frondosa, coix seeds, Chinese yam, lotus seeds, dendrobium, lucid ganoderma and American ginseng; also comprises theanine, tremella polysaccharide and phospholipid; the composition further comprises an antioxidant; the antioxidant is one or more of lycopene, tea polyphenol, vitamin E, rosemary extract and bamboo leaf antioxidant.
8. The nutritional composition for improving body inflammatory signs of patients with tumors according to claim 1, further comprising vitamins and minerals, wherein the minerals are one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamins are one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid and vitamin C.
9. The nutritional composition for improving body inflammatory signs of tumor patients according to claim 1, which is characterized by comprising, by weight, 20-30 parts of concentrated whey protein, 5-10 parts of hydrolyzed whey protein, 0.6 part of oligomannose, 0.6 part of tremella polysaccharide, 0.2 part of wheat oligopeptide, 0.2 part of marine fish bone collagen oligopeptide, 0.004 part of sea cucumber oligopeptide powder, 0.004 part of tea theanine, 0.2 part of oat β -glucan, 0.112 part of medlar powder, 0.088 part of tuckahoe powder, 0.088 part of sealwort powder, 0.06 part of dried orange peel powder, 0.3 part of vitamin, 1.7 parts of mineral source, 25-50 parts of compound vegetable fat powder, 2-10 parts of fish oil fat powder, 0.0008 part of lycopene, 0.5-1.5 part of edible essence and 20-35 parts of maltodextrin;
the compound vegetable fat powder is prepared by uniformly mixing one or more of olive oil, sunflower seed oil, coconut oil, silybum marianum seed oil, tea seed oil, palm oil and medium-chain triglyceride, and sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder; the fish oil fat powder is prepared by mixing fish oil, phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder;
the mineral source is one or more of iron, calcium, zinc, selenium, magnesium, copper, manganese, potassium and phosphorus, and the vitamin is one or more of vitamin A, β -carotene, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid and vitamin C.
10. A method for preparing a nutritional composition for improving the signs of body inflammation in a patient with a tumour according to claim 8 or 9, comprising the steps of:
mixing one or more of oleum Olivarum, oleum Helianthi, oleum Cocois, Silybum marianum seed oil, tea seed oil, palm oil and medium chain triglyceride, sequentially adding phospholipid, antioxidant, isomaltooligosaccharide and lactalbumin, stirring and mixing; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; carrying out spray drying on the transparent emulsion to obtain compound vegetable fat powder;
stirring and uniformly mixing fish oil, phospholipid, antioxidant, isomaltooligosaccharide and whey protein powder; adding water at a speed of 0.8-1.5KG/min while stirring until the emulsion becomes transparent; spray drying the transparent emulsion to obtain fish oil fat powder;
uniformly mixing the compound plant fat powder and the fish oil fat powder, sequentially adding concentrated whey protein, hydrolyzed whey protein, wheat oligopeptide, marine fish bone collagen oligopeptide, sea cucumber oligopeptide powder, oligomannose, tremella polysaccharide, oat β -glucan, tea theanine, medlar powder, rhizoma polygonati powder, tuckahoe powder, tangerine peel powder, vitamins, a mineral source, maltodextrin, lycopene and edible essence, and uniformly mixing to obtain the nutritional composition.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911227592.XA CN110839884A (en) | 2019-12-04 | 2019-12-04 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
CN202011158140.3A CN112089051A (en) | 2019-12-04 | 2020-10-26 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911227592.XA CN110839884A (en) | 2019-12-04 | 2019-12-04 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110839884A true CN110839884A (en) | 2020-02-28 |
Family
ID=69607519
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911227592.XA Pending CN110839884A (en) | 2019-12-04 | 2019-12-04 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
CN202011158140.3A Pending CN112089051A (en) | 2019-12-04 | 2020-10-26 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011158140.3A Pending CN112089051A (en) | 2019-12-04 | 2020-10-26 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN110839884A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111436597A (en) * | 2020-04-01 | 2020-07-24 | 山东若尧特医食品有限公司 | Lipid chain peptide and production process thereof |
CN111449247A (en) * | 2020-04-30 | 2020-07-28 | 山东省科学院生物研究所 | Tumor patient sea cucumber peptide nutritional supplement and processing method thereof |
CN111480838A (en) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | Nutrition composite powder for puerpera in lactation period and preparation method thereof |
CN113100444A (en) * | 2021-05-17 | 2021-07-13 | 天津正大珍吾堂食品股份有限公司 | Enteral nutrition support composition for tumor patients and/or postoperative population and preparation method thereof |
CN113575934A (en) * | 2021-08-02 | 2021-11-02 | 山东哈维药业有限公司 | Total-nutrient compound protein powder for tumor patients |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113558228A (en) * | 2021-05-20 | 2021-10-29 | 浙江核力欣健药业有限公司 | Special nutritional formula powder for tumor patients and preparation method thereof |
CN113575950A (en) * | 2021-08-06 | 2021-11-02 | 徐文红 | A nutritional product with adjuvant rehabilitation effect for radiotherapy and chemotherapy of cancer patients |
CN113907169A (en) * | 2021-11-05 | 2022-01-11 | 安吉三叶青生物科技有限公司 | Radix astragali buccal tablet and preparation method and application thereof |
CN114868890A (en) * | 2022-03-26 | 2022-08-09 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for tumor patients |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104207144B (en) * | 2014-09-26 | 2016-09-14 | 上海励成营养产品科技股份有限公司 | A kind of many polymerizers of high energy type enteral nutrition |
CN105707878A (en) * | 2016-04-19 | 2016-06-29 | 北京希康宁生物技术有限责任公司 | Full nutrition formulation food for tumors |
CN106616615A (en) * | 2016-12-23 | 2017-05-10 | 上海奥医生物医药科技有限公司 | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula |
CN108991500A (en) * | 2018-07-02 | 2018-12-14 | 邦世迪(广东)医用食品股份有限公司 | A kind of tumour patient full nutrition formula food |
-
2019
- 2019-12-04 CN CN201911227592.XA patent/CN110839884A/en active Pending
-
2020
- 2020-10-26 CN CN202011158140.3A patent/CN112089051A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111436597A (en) * | 2020-04-01 | 2020-07-24 | 山东若尧特医食品有限公司 | Lipid chain peptide and production process thereof |
CN111436597B (en) * | 2020-04-01 | 2023-05-12 | 山东若尧特医食品有限公司 | Lipotide and its production process |
CN111449247A (en) * | 2020-04-30 | 2020-07-28 | 山东省科学院生物研究所 | Tumor patient sea cucumber peptide nutritional supplement and processing method thereof |
CN111480838A (en) * | 2020-05-26 | 2020-08-04 | 辽宁康汇医学临床研究有限公司 | Nutrition composite powder for puerpera in lactation period and preparation method thereof |
CN113100444A (en) * | 2021-05-17 | 2021-07-13 | 天津正大珍吾堂食品股份有限公司 | Enteral nutrition support composition for tumor patients and/or postoperative population and preparation method thereof |
CN113575934A (en) * | 2021-08-02 | 2021-11-02 | 山东哈维药业有限公司 | Total-nutrient compound protein powder for tumor patients |
Also Published As
Publication number | Publication date |
---|---|
CN112089051A (en) | 2020-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110839884A (en) | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof | |
CN102940214B (en) | Fruit and vegetable fiber nutrition powder production and production method and application thereof | |
CN104207144B (en) | A kind of many polymerizers of high energy type enteral nutrition | |
CN103025178B (en) | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition | |
CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
CN108991500A (en) | A kind of tumour patient full nutrition formula food | |
CN101023802A (en) | Series products of all-nutrient green health-care bean vermicellic and instant bean vermicellic and preparing method | |
CN101971951A (en) | Yam flour with healthcare function and preparation method | |
CN108294306A (en) | A kind of full nutrition special medicine purposes formula food of amino acid pattern | |
CN104839707A (en) | Yin deficiency physique non-total nutrient formula food | |
CN109363037A (en) | It is a kind of multi-functional containing peptide beverage | |
CN109329902A (en) | A kind of leukemia of children tailored version clinical nutrition formula and preparation method thereof | |
CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
CN107890117A (en) | A kind of compound oligomeric peptide nutrient powder of WPC | |
CN104839698A (en) | Cardiovascular disease non-total nutrient formula food | |
CN104855968A (en) | Liver cancer non-complete nutrition formula food | |
CN109170888A (en) | A kind of anti-oxidant, anti-Fatigue Composition and preparation method thereof | |
CN108703376A (en) | A kind of short peptide type many polymerizers of the EA | |
CN103445168B (en) | Compound trepang particle chewable tablet and preparation method thereof | |
CN104855992A (en) | Whole nutrient formula food for prostatic cancer | |
CN101797049B (en) | Nutrient eight-treasure soup formula and preparation process thereof | |
CN104855969A (en) | Non-whole nutrient formula food for liver diseases | |
US20230355685A1 (en) | Raw material production from stichopus variegatus | |
CN104855971A (en) | Non-total-nutrient formula food for osteoma | |
CN104856011A (en) | Non-total-nutrient formula food for tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200228 |